Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (41 ops.)
Latest filing published 07 Oct 2026 for Recursion Pharmaceuticals, INC., €49k. Read the official filing
Filing timeline
BuySaleRobert Hershberg
Insider track record
Disclosed buys
0
Disclosed sells
41
Signal history
Robert Hershberg: trading record in brief
Robert Hershberg (board member) discloses dealings in 6 companies, chiefly Adaptive Biotechnologies Corp, NanoString Technologies Inc and Recursion Pharmaceuticals, Inc. Over a trading history stretching from 23 April 2020 to 6 October 2026, the count stands at 82 filings.
On the market, this insider has only sold: 41 sales, €4.1M in total. The rest of the record consists of 15 share grants and 25 option exercises. 2026 to date brings no purchases and 4 sales.
On 7 October 2026 came the latest disclosure, an option exercise for €49k in Recursion Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert Hershberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
25,000 shares@ US$2.22Class A Common StockSEC:0001601830-26-000119:0
25,000 shares@ US$5.00Class A Common StockSEC:0001601830-26-000119:1
15,000 shares@ US$6.320.0021% mcap5.7% of flowCommon StockSEC:0001274139-26-000004:0
15,000 shares@ US$24.390.0081% mcap22.0% of flowCommon StockSEC:0001274139-26-000004:1
15,664 shares@ US$24.410.0084% mcap23.0% of flowCommon StockSEC:0001274139-26-000004:2
48,858 shares@ US$1.350.0024% mcap10.5% of flowCommon StockSEC:0001140361-26-028137:0
51,142 shares@ US$1.350.0025% mcap10.9% of flowCommon StockSEC:0001140361-26-028137:1
100,000 shares@ US$4.960.018% mcap78.6% of flowCommon StockSEC:0001140361-26-028137:2
15,625 shares0Common StockSEC:0001274139-26-000001:0
22,968 shares@ US$16.0022.0% of flowCommon StockSEC:0001274139-25-000003:0
1,101,498 sharesCommon StockSEC:0001193125-25-206257:0
22,016 shares0Class A Common StockSEC:0001601830-25-000110:0
53,000 shares@ US$7.5925.7% of flowCommon StockSEC:0001062993-25-005300:0
15,394 shares0Common StockSEC:0001062993-25-004803:0
14,634 shares@ US$1.8914.3% of flowCommon StockSEC:0000950170-25-018822:0
13,097 shares0Class A Common StockSEC:0001601830-24-000072:0
31,328 shares0Common StockSEC:0001062993-24-005772:0
11,597 shares@ US$14.931585.7% of flowCommon StockSEC:0000950170-24-014063:0
12,612 shares0Class A Common StockSEC:0001209191-23-038840:0
14,775 shares0Common StockSEC:0001062993-23-006334:0
187,966 shares0Common StockSEC:0000899243-23-003852:0
53,000 shares@ US$0.451.5% of flowCommon StockSEC:0001209191-23-006994:0
18,145 shares0Class A Common StockSEC:0001209191-22-037637:0
8,650 shares0Common StockSEC:0001209191-22-036347:0
672 shares@ US$22.75100.0% of flowCommon StockSEC:0001209191-22-034546:0
25 of 32 declarations
